Showing results (511-520 of 607) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|October 31, 2025
Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology AssessmentTobias Sydendal Grand, Shijie Ren, Praveen Thokala, et al.
Pharmacoeconomics - Open|August 12, 2025
Treatment (as Prevention) Availability and Individuals' Behavior: A Cost-Effectiveness Analysis of Cabotegravir Long-Acting Injectable PrEPJ Felipe Montano-Campos, Blythe Adamson
Pharmacoeconomics - Open|October 24, 2020
Can Private Provision of Primary Care Contribute to the Spread of Antibiotic Resistance? A Study of Antibiotic Prescription in SwedenDavid Granlund, Yana V Zykova
Pharmacoeconomics - Open|October 27, 2020
Investigation of Factors Considered by Health Technology Assessment Agencies in Eight CountriesAkira Yuasa, Naohiro Yonemoto, Sven Demiya, et al.
Pharmacoeconomics - Open|November 23, 2020
Attributable Cost of Adult Hospitalized Pneumonia Beyond the Acute PhaseDerek Weycker, Aaron Moynahan, Amanda Silvia, et al.
Pharmacoeconomics - Open|June 22, 2022
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based AnalysisNafsika Afentou, Emma Frew, Samir Mehta, et al.
Pharmacoeconomics - Open|January 7, 2021
Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and ImplicationsCharles Ebuka Okafor
Pharmacoeconomics - Open|June 1, 2021
Hospital Costs of Extracorporeal Membrane Oxygenation in Adults: A Systematic ReviewAnnemieke Oude Lansink-Hartgring, Olivier van Minnen, Karin M Vermeulen, et al.
Pharmacoeconomics - Open|December 1, 2022
Cost-effectiveness Analysis of Ocrelizumab for the Treatment of Relapsing and Primary Progressive Multiple Sclerosis in PortugalPaulo Martins, Björn Vandewalle, Jorge Félix, et al.
Pharmacoeconomics - Open|June 24, 2022
Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data AnalysisZeki Kocaata, Thomas Wilke, Franz Fischer, et al.
Pageof 61